General
Preferred name
APRICITABINE
Synonyms
AVX754 ()
SPD754 ()
Pharmaprojects No. 4701 ()
SPD-754 ()
BCH-10652, (-)- ()
Apricitabina ()
SPD -754 ()
AVX-754 ()
BCH-10618 ()
P&D ID
PD058417
CAS
160707-69-7
Tags
available
prodrug
drug candidate
Drug indication
HIV infection
Human immunodeficiency virus infection
Drug Status
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
538
DESCRIPTION
Apricitabine (SPD754) is a highly selective and orally active HIV-1 reverse transcriptase inhibitor (Ki=0.08 ??M), the (-) enantiomer of 2??-deoxy-3??-oxy-4??-thiocytidine (dOTC) . Apricitabine inhibits DNA polymerase ??, ?? and ?? with Ki values of 300 ??M, 12 ??M and 112.25 ??M, respectively. Apricitabine has shown good antiretroviral therapeutic efficacy in antiretroviral HIV-infected patients, with good tolerability and low selective resistance.
DESCRIPTION
Apricitabine is a nucleoside reverse transcriptase inhibitors (NRTI) class antiretriviral drug that is structurally related to and emtricitabine. It is a cytidine derivative.
(GtoPdb)
DESCRIPTION
Apricitabine (SPD754) is a highly selective and orally active HIV-1 reverse transcriptase inhibitor (Ki=0.08 μM), the (-) enantiomer of 2′-deoxy-3′-oxy-4′-thiocytidine (dOTC) . Apricitabine inhibits DNA polymerase α, β and γ with Ki values of 300 μM, 12 μM and 112.25 μM, respectively. Apricitabine has shown good antiretroviral therapeutic efficacy in antiretroviral HIV-infected patients, with good tolerability and low selective resistance.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
8
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
229.05
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
1
cLogP
-0.59
TPSA
90.37
Fraction CSP3
0.5
Chiral centers
2.0
Largest ring
6.0
QED
0.7
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
HIV-1 reverse transcriptase
DNA polymerase α
DNA polymerase beta
DNA polymerase γ
MOA
nucleoside reverse transcriptase inhibitor
Pathway
Cell Cycle/Checkpoint
DNA Damage/DNA Repair
Microbiology/virology
Proteases/Proteasome
Source data
